- Zeynep ÖZSARAN, Deniz YALMAN, Morteza PARVİZİ, Arif ARAS, Ayfer HAYDAROĞLU, Yıldız ERHAN: İnflamatuar Meme Karsinomlu Olgularda radyoterapi Sonuçlarımız. Meme Hastalıkları Dergisi, Vol 9, Sayı 3, Temmuz-Eylül 2002.
|
- Zeynep ÖZSARAN, Deniz YALMAN, Gökçen YILDIRIM, Morteza PARVİZİ, Mustafa ESASSOLAK, Ayfer HAYDAROĞLU: Baş-Boyun Kanseri Tanısı İle Radyoterapi Gören Olgularda Geç Yan Etkilerin Değerlendirilmesi. Türkiye Klinikleri Tıp Bilimleri Dergisi, Cilt:23, Sayı:3 Haziran 2003.
|
- Ozlem Tokusoglu, Alkan Simsek, Murtaza Parvizi, Dilvin Eymen: Turmeric curcuminoid polyphenolics as antioxidant and anticarcinogenic agents. Natural Science and Discovery, 2015; 1(3): 56-61.
|
- Hakan Türk, Sitki Ün, Ahmet Cinkaya, Hilmi kodaz, Murtaza PARVİZİ, Ferruh Zorlu: The Effect of Delayed Radical Cystectomy in Invasive Bladder Tumors on Lymph Node Positivity and Cancer-specific and Total Survival, Tumori 2017; 00(00):000-000, DOİ: 10.5301/tj.5000626
|
- Ozlem Ozkaya Akagunduz, Arzu Ergen, Petek Erpolat, Melis Gultekin, Berna Akkus Yildirim, Murteza Parvizi, Didem Ikiz, Didem Colpan Oksuz, Cem Onal, Ferah Yildiz, Zeynep Ozsaran: Local recurrence outcomes after breast conserving surgery and adjuvant radiotherapy in ductal carcinoma in situ of the breast and a comparison with ECOG E5194 study, The Breast 42 (2018) 10-14. DOİ: 10.1016/j.breast.2018.08.094.
|
- Umut Varol, Yusuf Uzum, Adem Sengul, Ugur Bayram Korkmaz, Murtaza Parvizi, Murat Akyol, Halil Taskaynatan, Tarik Salman, Utku Oflazoglu, Yasar Yildiz, Ahmet Alacacioglu, Yuksel Kucukzeybek, Mustafa Oktay Tarhan: An analysis of adjuvant treatment strategies in operated pancreatic cancer patients: An Izmir oncology group study, Indian Journal of Cancer 57 (2020) 158-163. DOI: 10.4103/ijc.IJC_318_18
|
- Semra AY, Murtaza PARVİZİ: The Functional Assessment of Cancer Therapy General (FACT-G) Scale: Reliability and Validity of a Turkish Version; CBU-SBED, 2021, 8(2): 198-203
|
- Elif Tuğba Tuncel, Murtaza Parvizi, Engin Kut, Mesut Aydın, Elmas Kasap: Prognostic Significance of H/PNI (Hemoglobin/Prognostic Nutritional Index) and H/RDW (Hemoglobin/Red Blood Cell Distribution) in Rectal Cancer; Turk J Gastroenterol, 2022 Dec 13. doi: 10.5152/tjg.2022.22203.
|
- Cumhur Yıldırım, Gulnihan Eren Kupik, Teuta Zoto Mustafayev, Tanju Berber, Berrin Yavuz, Oguz Çetinayak, Ozlem Akagunduz, Beyhan Ceylaner Bıçakçı, Süheyla Aytaç Arslan, Ela Delikgoz Soykut, Mete Gundog, Metin Figen, Fatma Teke, Emine Canyılmaz, Sumerya Duru Birgi, Mursel Duzova, Sefik İgdem, Candan Demiroz Abakay, Beste Atasoy, Nuri Kaydıhan, Murtaza Parvizi, Gonca Hanedan Uslu, Halil Sagınç, Fadime Akman, Enis Özyar: A multicenter retrospective analysis of patients with nasopharyngeal carcinoma treated in IMRT era from a nonendemic population: Turkish Society for Radiation Oncology Head and Neck Cancer Group Study (TROD 01-001). Head & Neck. 2023;1–12. DOI: 10.1002/hed.27333
|
- Murtaza Parvizi, Derya Demir, Engin Kut, Erhan Ergin, Semin Ayhan, Başak Doğanavşargil. Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer. Ann Clin Anal Med 2023; 14(Suppl 1):S:86-89.
|
- Parvizi M, Kut E, Akyol M, Ay S. Effect of Postoperative Adjuvant Radiotherapy on Quality of Life, Anxiety, and Depression in Adult Female Breast Cancer Patients. (March 24, 2023) Cureus 15(3): e36635. doi:10.7759/cureus.36635
|
- Murtaza PARVİZİ, Serdar ÖZKÖK, Gürsel ÇOK, Deniz YALMAN, Ayfer HAYDAROĞLU: Lokal İleri Küçük Hücreli Dışı Akciğer Kanserinde (KHDAK) Hipofraksiyone Radyoterapi. İzmir Göğüs Hastanesi Dergisi (Journal of İzmir Chest Hospital) 2023;37(1): 1-7. doi: 10.14744/IGH.2023.03016
|
- Sule KARABULT GUL, Huseyin TEPETAM, Ferah YILDIZ, Ilhami ER, Didem COLPAN OKSUZ, Murtaza PARVİZİ, Ayse Sevgi OZDEN, Zumre ARICAN ALICIKUS, Sezin YUCE SARI, Omar ALMORADİ, Ilknur BILKAY GORKEN. Revisiting The Radical Radiotherapy-Radiochemotherapy Results in Anal Canal Cancers: (TROD Gastrointestinal Group Study 02-005). Clinical Colorectal Cancer May 22 2023; doi: https://doi.org/10.1016/j.clcc.2023.05.00
|
- Mihriban Erdogan MD, Murtaza Parvizi MD, Zeliha Güzelöz MD: RADIOCHEMOTERAPY RELATED LYMPHOPENIA IN HEAD AND NECK CANCER. Turk J Oncol 2023;38(4):382–91 doi: 10.5505/tjo.2023.4017
|
- Halil Cumhur Yıldırım M.D, Fazilet Öner Dinçbaş, Volkan Demircan, Murat Beyzadeoğlu, Ertuğrul Tekçe, Gözde Yazıcı, Menekşe Turna, Oğuz Çetinayak, Kudret Ensarioğlu Baktır, Mustafa Akın, Emine Canyılmaz, Ayse Altınok, Ela Delikgöz Soykut, Müge Akmansu, Fuzuli Tuğrul, Seda Ünverdi, Berrin Benli Yavuz, Serra Kamer, Mürsel Düzova, Sumerya Duru Birgi, Emine Elif Özkan, Berrin Yalçın, Merve Şahin, Durmuş Etiz, Hasan Suat Arslantaş, Deniz Meydan, Şefik İğdem, Halil Sağınç, Murtaza Parvizi, Pelin Altınok, Yavuz Anacak. Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish Society for Radiation Oncology (TROD 05-002). Strahlenther Onkol. 2023 Oct 5. doi: 10.1007/s00066-023-02154-x. Epub ahead of print. PMID: 37796342.
|
- Murtaza Parvizi, Ulkun Unsal Unlu, Olcay Ak Nalbent, Derya Demir, Murat Akyol, Aydın İsisag: Correlation of IDH1, p53 and Ki-67 immunoexpression levels with morphological, clinical prognostic parameters and preoperative/postoperative radiological findings and response to treatment in high-grade glial tumor cases. Medicine Science 2023;12(4):1331-6
|
- Zeliha Güzelöz; İlknur Bilkay Görken; Barbaros Aydın; Fatma Sert; Deniz Yalman; Murtaza Parvazi; Gülhan Güler Avcı; Pelin Altınok; Hatice Halis; Şefika Arzu Ergen; Züleyha Akgün; Elif Özkan; Yıldız Güney; Didem Karaçetin; Nuri Kaydıhan; Mürsel Düzova; Murat Akın; Bora Uysal; Mihriban Erdoğan; Hülya Ellidokuz; Gamze Aksu; Evrim Metcalfe. Evaluation of Treatment Outcomes and Tolerability in Older Patients with Rectal Cancer Treated with Radiotherapy Accompanied by the G-8 Geriatric Score: TROD13-003 Multi-center Study. Journal of Geriatric Oncology 15 (2024) 101739. https://doi.org/10.1016/j.jgo.2024.101739
|
- Derya Demir, Murtaza Parvizi, Burcin Pehlivanoglu, Erhan Ergin, Semin Ayhan, Basak Doganavsargil: The Association of the Epidermal Growth Factor Receptor (EGFR) Immunoexpression With Prognostic Parameters in Adenocarcinoma Patients Receiving Neoadjuvant Treatment. Cureus 16(3): e56763. DOI 10.7759/cureus.56763
|